Haplotype-specific expression of the human PDGFRA gene correlates with the risk of glioblastomas

International Journal of Cancer

Volumn 123, Issue 2, 2008, Pages 322-329

  Toepoel, Mascha ^a,e   Joosten, Paul H L J ^a   Knobbe, Christiane B ^b   Afink, Gijs B ^c,f   Zotz, Rainer B ^b   Steegers Theunissen, Regine P M ^d   Reifenberger, Guido ^b   Van Zoelen, Everardus J J ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UPPSALA UNIVERSITY   (Sweden)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e GHENT UNIVERSITY   (Belgium)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Allele specific expression; Case control study; DNA methylation; Glioblastoma; PDGFRA promoter haplotype

Indexed keywords

DNA; HISTONE; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR;

ACETYLATION; ADULT; AGED; ALLELE; ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CELL SIZE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; GENE CONTROL; GENE EXPRESSION; GENETIC CORRELATION; GENETIC PREDISPOSITION; GENETIC RISK; GLIOBLASTOMA; HAPLOTYPE; HETEROZYGOTE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROMOTER REGION; UPREGULATION; WESTERN EUROPE; CHEMISTRY; EUROPE; GENE EXPRESSION REGULATION; GENETICS; INCIDENCE; METABOLISM; MIDDLE AGED; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR;

ACETYLATION; ADULT; AGED; CASE-CONTROL STUDIES; DNA METHYLATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EUROPE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GLIOBLASTOMA; HAPLOTYPES; HISTONES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROMOTER REGIONS (GENETICS); RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; RNA, MESSENGER; UP-REGULATION;

EID: 44949120621     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23432     Document Type: Article

References (66)

1. Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 1988;333:560-2.
2. Armstrong RC, Harvath L, Dubois-Dalcq ME. Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules. J Neurosci Res 1990;27:400-7.
3. Zhang H, Vutskits L, Calaora V, Durbec P, Kiss JZ. A role for the polysialic acid-neural cell adhesion molecule in PDGF-induced Chemotaxis of oligodendrocyte precursor cells. J Cell Sci 2004;117:93-103.
4. Woodruff RH, Fruttiger M, Richardson WD, Franklin RJ. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol Cell Neurosci 2004;25:252-62.
5. Fruttiger M, Karlsson L, Hall AC, Abramsson A, Calver AR, Bostrom H, Willetts K, Bertold CH, Heath JK, Betsholtz C, Richardson WD. Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. Development 1999;126:457-67.
6. Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois-Dalcq M. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 1988;53:309-19.
7. Pringle NP, Mudhar HS, Collarini EJ, Richardson WD. PDGF receptors in the rat CNS: during late neurogenesis. PDGF α-receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage. Development 1992;115:535-51.
8. McKinnon RD, Waldron S, Kiel ME. PDGF α-receptor signal strength controls an RTK rheostat that integrates phosphoinositol 3′-kinase and phospholipase Cγ pathways during oligodendrocyte maturation. J Neurosci 2005;25:3499-508.
9. Murtie JC, Zhou YX, Le TQ, Vana AC, Armstrong RC. PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination. Neurobiol Dis 2005;19:171-82.
10. Li L, Schatteman GC, Oppenheim RW, Lei M, Bowen-Pope DF, Houenou LJ. Altered development of spinal cord in the mouse mutant (Patch) lacking the PDGF receptor α-subunit gene. Brain Res Dev Brain Res 1996;96:204-9.
11. Payne J, Shibasaki F, Mercola M. Spina bifida occulta in homozygous Patch mouse embryos. Dev Dyn 1997;209:105-16.
12. Soriano P. The PDGF αreceptor is required for neural crest cell development and for normal patterning of the somites. Development 1997;124:2691-700.
13. Klinghoffer RA, Hamilton TG, Hoch R, Soriano P. An allelic series at the PDGFαR locus indicates unequal contributions of distinct signaling pathways during development. Dev Cell 2002;2:103-13.
14. Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B, Nister M. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 1992;52:3213-19.
15. Di Rocco F, Carroll RS, Zhang J, Black PM. Platelet-derived growth factor and its receptor expression in human oligodendrogliomas. Neurosurgery 1998;42:341-6.
16. Lokker NA, Sullivan CM, Hollenbach SJ, Israel MA, Giese NA. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res 2002;62:3729-35.
17. Fleming TP, Saxena A, Clark WC, Robertson JT, Oldfield EH. Aaronson SA, Ali IU. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res 1992;52:4550-3.
18. Smith JS, Wang XY, Qian J, Hosek SM, Scheithauer BW, Jenkins RB, James CD. Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features. J Neuropathol Exp Neurol 2000;59:495-503.
19. Knobbe CB, Reifenberger G. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3′-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol 2003;13:507-18.
20. Joensuu H, Puputti M, Sihto H, Tynninen O, Nupponen NN. Amplification of genes encoding KIT, PDGFRα and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme. J Pathol 2005;207:224-31.
21. Suzuki T, Maruno M, Wada K, Kagawa N, Fujimoto Y, Hashimoto N, Izumoto S, Yoshimine T. Genetic analysis of human glioblastomas using a genomic microarray system. Brain Tumor Pathol 2004;21:27-34.
22. Uhrbom L, Hesselager G, Nister M, Westermark B. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res 1998;58:5275-9.
23. Uhrbom L, Hesselager G, Ostman A, Nister M, Westermark B. Dependence of autocrine growth factor stimulation in platelet-derived growth factor-B-induced mouse brain tumor cells. Int J Cancer 2000;85:398-406.
24. Shih AH, Dai C, Hu X, Rosenblum MK, Koutcher JA, Holland EC. Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis. Cancer Res 2004;64:4783-9.
25. Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN, Holland EC. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 2001;15:1913-25.
26. Joosten PH, Toepoel M, Mariman EC, Van Zoelen EJ. Promoter haplotype combinations of the platelet-derived growth factor α-receptor gene predispose to human neural tube defects. Nat Genet 2001;27:215-17.
27. Toepoel M, Ackerschott B, van Zoelen EJ. Haplotype-dependent binding of nuclear proteins to the promoter of the neural tube defects-associated platelet-derived growth factor α-receptor gene. Biochim Biophys Acta 2005;1741:350-7.
28. Zhu H, Wicker NJ, Volcik K, Zhang J, Shaw GM, Lammer EJ, Suarez L, Canfield M, Finnell RH. Promoter haplotype combinations for the human PDGFRA gene are associated with risk of neural tube defects. Mol Genet Metab 2004;81:127-32.
29. Au KS, Northrup H, Kirkpatrick TJ, Volcik KA, Fletcher JM, Townsend IT, Blanton SH, Tyerman GH, Villarreal G, King TM. Promotor genotype of the platelet-derived growth factor receptor-α gene shows population stratification but not association with spina bifida meningomyelocele. Am J Med Genet A 2005;139:194-8.
30. Herrmann SM, Ricard S, Nicaud V, Brand E, Behague I, Blanc H, Ruidavets JB, Evans A, Arveiler D, Luc G, Poirier O, Cambien F. Polymorphisms in the genes encoding platelet-derived growth factor A and αreceptor. J Mol Med 2000;78:287-92.
31. De Bustos C, Smits A, Stromberg B, Collins VP, Nister M, Afink G. A PDGFRA promoter polymorphism, which disrupts the binding of ZNF148, is associated with primitive neuroectodermal tumours and ependymomas. J Med Genet 2005;42:31-7.
32. van den Boom J, Wolter M, Kuick R, Misek DE, Youkilis AS, Wechsler DS, Sommer C, Reifenberger G, Hanash SM. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 2003;163:1033-43.
33. Groenen PM, Peer PG, Wevers RA, Swinkels DW, Franke B, Mariman EC, Steegers-Theunissen RP. Maternal myo-inositol, glucose, and zinc status is associated with the risk of offspring with spina bifida. Am J Obstet Gynecol 2003;189:1713-19.
34. Groenen PM, Klootwijk R, Schijvenaars MM, Straatman H, Mariman EC, Franke B, Steegers-Theunissen RP. Spina bifida and genetic factors related to myo-inositol, glucose, and zinc. Mol Genet Metab 2004;82:154-61.
35. Nister M, Wedell B, Betsholtz C, Bywater M, Pettersson M, Westermark B, Mark J. Evidence for progressional changes in the human malignant glioma line U-343 MGa: analysis of karyotype and expression of genes encoding the subunit chains of platelet-derived growth factor. Cancer Res 1987;47:4953-60.
36. Nister M, Heldin CH, Westermark B. Clonal variation in the production of a platelet-derived growth factor-like protein and expression of corresponding receptors in a human malignant glioma. Cancer Res 1986;46:332-40.
37. Nister M, Westermark B. Human glioma cell lines. In: Hay RJ, ed. Atlas of human tumor cell lines. San Diego: Academic Press, 1994.17-42.
38. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
39. Vaes BL, Dechering KJ, van Someren EP, Hendriks JM, van de Ven CJ, Feijen A, Mummery CL, Reinders MJ, Olijve W, van Zoelen EJ, Steegenga WT. Microarray analysis reveals expression regulation of Wnt antagonists in differentiating osteoblasts. Bone 2005;36:803-11.
40. Ostman A. PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine Growth Factor Rev 2004;15:275-86.
41. 4L Kaetzel DM, Reid JD, IV, Pedigo N, Zimmer SG, Boghaert ER. A dominant-negative mutant of the platelet-derived growth factor A-chain increases survival of hamsters implanted intracerebrally with the highly invasive CxT24-neo3 glioblastoma cell. J Neurooncol 1998;39:33-46.
42. Kubota H, Nishizaki T, Harada K, Oga A, Ito H, Suzuki M, Sasaki K. Identification of recurrent chromosomal rearrangements and the unique relationship between low-level amplification and translocation in glioblastoma. Genes Chromosomes Cancer 2001;31:125-33.
43. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, Fine HA. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006;9:391-403.
44. Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science 2001;293:1068-70.
45. Gonzalgo ML, Hayashida T, Bender CM, Pao MM, Tsai YC, Gonzales FA, Nguyen HD, Nguyen TT, Jones PA. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. Cancer Res 1998;58:1245-52.
46. Hinds DA, Stuve LL, Nilsen GB, Halperin E, Eskin E, Ballinger DG, Frazer KA, Cox DR. Whole-genome patterns of common DNA variation in three human populations. Science 2005;307:1072-9.
47. Hess KR, Broglio KR, Bondy ML. Adult glioma incidence trends in the United States, 1977-2000. Cancer 2004;101:2293-9.
48. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol (Berl) 2005;109:93-108.
49. Barnholtz-Sloan JS, Sloan AE, Schwartz AG. Racial differences in survival after diagnosis with primary malignant brain tumor. Cancer 2003;98:603-9.
50. Das A, Tan WL, Teo J, Smith DR. Glioblastoma multiforme in an Asian population: evidence for a distinct genetic pathway. J Neurooncol 2002;60:117-25.
51. Lary JM, Edmonds LD. Prevalence of spina bifida at birth - United States, 1983-1990: a comparison of two surveillance systems. MMWR CDC Surveill Summ 1996;45:15-26.
52. Feuchtbaum LB, Currier RJ, Riggle S, Roberson M, Lorey FW, Cunningham GC. Neural tube defect prevalence in California (1990-1994): eliciting patterns by type of defect and maternal race/ethnicity. Genet Test 1999;3:265-72.
53. Hall A, Giese NA, Richardson WD. Spinal cord oligodendrocytes develop from ventrally derived progenitor cells that express PDGF α-receptors. Development 1996;122:4085-94.
54. Hu JG, Fu SL, Zhang KH, Li Y, Yin L, Lu PH, Xu XM. Differential gene expression in neural stem cells and oligodendrocyte precursor cells: a cDNA microarray analysis. J Neurosci Res 2004;78:637-46.
55. Calver AR, Hall AC, Yu WP, Walsh FS, Heath JK, Betsholtz C, Richardson WD. Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron 1998;20:869-82.
56. van Heyningen P, Calver AR, Richardson WD. Control of progenitor cell number by mitogen supply and demand. Curr Biol 2001;11:232-41.
57. Zhu Y, Parada LF. The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2002;2:616-26.
58. Jackson EL, Garcia-Verdugo JM, Gil-Perotin S, Roy M, Quinones-Hinojosa A, Vandenberg S, Alvarez-Buylla A. PDGFRα-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron 2006;51:187-99.
59. Yuan X, Curtin J, Xiong Y, Liu G, Waschsmann-Hogiu S, Farkas DL, Black KL, Yu JS. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004;23:9392-400.
60. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F, Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004;64:7011-21.
61. Enblad P, Hesselager G, Bongcam-Rudloff E, Hallin I, Westermark B, Nister M. Modulation of phenotype and induction of irregular vessels accompany high tumorigenic potential of clonal human glioma cells xenografted to nude-rat brain. Int J Cancer 2000;85:819-28.
62. Zheng X, Shen G, Yang X, Liu W. Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res 2007;67:3691-7.
63. Charron J, Malynn BA, Fisher P, Stewart V, Jeannotte L, Goff SP, Robertson EJ, Alt FW. Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev 1992;6:2248-57.
64. Lassus H, Sihto H, Leminen A, Nordling S, Joensuu H, Nupponen NN, Butzow R. Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma. Br J Cancer 2004;91:2048-55.
65. Sulzbacher I, Birner P, Trieb K, Muhlbauer M, Lang S, Chott A. Platelet-derived growth factor-α receptor expression supports the growth of conventional chondrosarcoma and is associated with adverse outcome. Am J Surg Pathol 2001;25:1520-7.
66. Sulzbacher I, Birner P, Trieb K, Traxler M, Lang S, Chott A. Expression of platelet-derived growth factor-AA is associated with tumor progression in osteosarcoma. Mod Pathol 2003;16:66-71.